ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $867,000 | -13.6% | 33,367 | -5.0% | 0.00% | – |
Q1 2024 | $1,004,000 | -34.7% | 35,109 | -30.2% | 0.00% | – |
Q4 2023 | $1,537,000 | +68.9% | 50,273 | +48.6% | 0.00% | – |
Q3 2023 | $910,000 | -42.4% | 33,837 | -23.6% | 0.00% | – |
Q2 2023 | $1,579,000 | +194.0% | 44,301 | +109.3% | 0.00% | – |
Q1 2023 | $537,000 | -84.1% | 21,170 | -74.5% | 0.00% | -100.0% |
Q4 2022 | $3,369,000 | +58.8% | 83,058 | +29.3% | 0.00% | 0.0% |
Q3 2022 | $2,122,000 | -0.7% | 64,256 | +5.9% | 0.00% | 0.0% |
Q2 2022 | $2,136,000 | -25.7% | 60,672 | -2.9% | 0.00% | 0.0% |
Q1 2022 | $2,873,000 | -50.7% | 62,474 | -28.9% | 0.00% | 0.0% |
Q4 2021 | $5,828,000 | +32.1% | 87,896 | +24.4% | 0.00% | 0.0% |
Q3 2021 | $4,411,000 | -12.2% | 70,633 | +16.4% | 0.00% | 0.0% |
Q2 2021 | $5,025,000 | +6.6% | 60,673 | -14.7% | 0.00% | 0.0% |
Q1 2021 | $4,715,000 | -29.6% | 71,098 | -18.5% | 0.00% | -50.0% |
Q4 2020 | $6,693,000 | +52.1% | 87,240 | -17.6% | 0.00% | 0.0% |
Q3 2020 | $4,401,000 | -24.9% | 105,903 | -21.9% | 0.00% | 0.0% |
Q2 2020 | $5,857,000 | +73.4% | 135,603 | +15.5% | 0.00% | 0.0% |
Q1 2020 | $3,378,000 | -56.7% | 117,374 | -4.6% | 0.00% | -33.3% |
Q4 2019 | $7,803,000 | +308.3% | 123,030 | +81.5% | 0.00% | +200.0% |
Q3 2019 | $1,911,000 | +1.2% | 67,782 | -4.9% | 0.00% | 0.0% |
Q2 2019 | $1,889,000 | +46.1% | 71,303 | +1.2% | 0.00% | 0.0% |
Q1 2019 | $1,293,000 | +114.4% | 70,461 | +45.1% | 0.00% | – |
Q4 2018 | $603,000 | +92.0% | 48,567 | +196.4% | 0.00% | – |
Q3 2018 | $314,000 | +65.3% | 16,388 | +17.6% | 0.00% | – |
Q2 2018 | $190,000 | +400.0% | 13,932 | +162.0% | 0.00% | – |
Q1 2018 | $38,000 | +280.0% | 5,317 | +87.7% | 0.00% | – |
Q4 2017 | $10,000 | -67.7% | 2,832 | -60.7% | 0.00% | – |
Q3 2017 | $31,000 | +520.0% | 7,208 | +127.9% | 0.00% | – |
Q2 2017 | $5,000 | -72.2% | 3,163 | -68.3% | 0.00% | – |
Q1 2017 | $18,000 | +12.5% | 9,984 | -5.5% | 0.00% | – |
Q4 2016 | $16,000 | -70.4% | 10,564 | +42.6% | 0.00% | – |
Q3 2016 | $54,000 | +5.9% | 7,408 | -24.1% | 0.00% | – |
Q2 2016 | $51,000 | – | 9,758 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |